Kidney stone registry for adults who can consent
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is a global registry that collects information about people treated for kidney stones. It helps researchers learn about patterns of care and outcomes so treatments can improve over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You can understand the study and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “biomarkers,” which are measurable signs in samples like urine or blood, to help understand and detect recurring urinary stone disease. It may help future patients by improving how doctors predict stone recurrence or identify stone types.
This registry collects information on people being treated for kidney stones (urolithiasis) to help doctors learn which treatments work best. It includes patients of any age who have a medical reason for treatment and who allow their records to be used.
This study looks at the amount of tiny plastic particles (microplastics) in urine from people with kidney or ureter stones. The goal is to see if these particles are linked to stone formation, which could help prevent stones in the future.
This trial tests a robot-assisted telescope-guided procedure to break up kidney stones. It may be an option if you have a kidney stone smaller than about 1.6 cm and are already scheduled for a ureteroscopy (RIRS).
This trial compares a robot-assisted method to the standard procedure for removing kidney stones. It aims to see if the robotic approach is safer or more effective.
This study looks for better ways to predict when kidney stones may come back and what complications might happen. It may help doctors personalize follow-up and prevention plans based on information collected from you.
Hear when a new Urolithiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.